Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2023

MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Helping Implement Solutions Across Changing Financial Landscape

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a company formed to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. “With digital money replacing physical cash, consumers buy … Continue reading

Posted in Fintech Ecosystem Development Corp. FEXD | Leave a comment

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Participation for Upcoming Investor Conferences

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced its participation in investor conferences taking place in September 2023. The company’s Chief Financial Officer Hull Xu and Senior VP of Business Development Mitch Hourtienne … Continue reading

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Exec Featured in Recent The Market Herald Release

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, is being spotlighted in the most recent The Watchlist segment released by The Market … Continue reading

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) One of Three Quantum Computing Stocks Featured in InvestorPlace Article

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was one of three stocks listed in a recent InvestorPlace article. The article, titled “These Are the Only Quantum Computing Stocks to Consider in August 2023,” noted … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Update on IND Application Progress

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an update on the status of its anticipated submission of an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for the … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Robust Initial Inferred MRE for Iska Iska Project

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced the inaugural mineral resource estimate (“MRE”) for the Iska Iska silver-tin polymetallic project in the Potosi Department of southwestern Bolivia. The MRE was prepared by independent qualified persons (“QPs”) with … Continue reading

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs Deployed for Illinois-Based Casino and Fifth-Year Running for Huntington Park Police Department

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new deployment at an Illinois casino property utilizing a K5 ASR. In addition, the Huntington Park (California) Police Department renewed … Continue reading

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Update on Stock Buyback Program, File Suit Against Schwab, TD Ameritrade for Naked Short Selling

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its stock buyback program. The buyback program started on Aug. 16, 2023, and could go through Dec. 31, 2023. According to the announcement, the company has repurchased … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

Genprex Inc. (NASDAQ: GNPX) Celebrates Receipt of Orphan Drug Designation, Third Fast Track Designation Amid Preparations for Planned Acclaim-3 Clinical Trial

Genprex (NASDAQ: GNPX), a clinical-stage company developing life-changing gene therapies for patients with cancer and diabetes, recently celebrated an important milestone: the award of an orphan drug designation. The company announced August 10 that the United States Food and Drug … Continue reading

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Filing of Lawsuit Against Large Stock Brokerage Firms

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed a lawsuit in the United States District Court, in the Southern District of New York, against TD Ameritrade, Charles Schwab, National Finance Services and … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment